Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated December 28, 2021, titled "Sun Pharma receives DCGI approval for Molxvir�� (Molnupiravir) in India ".
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated December 28, 2021, titled "Sun Pharma receives DCGI approval for Molxvir�� (Molnupiravir) in India ".